ADAR1 Capital Management, LLC
Q3 2025 13F Holdings
- Locationaustin, TX
- Num holdings
217
- Value ($000)
$1,064,573
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001940272
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ABIVAX SA | SPONSORED ADS | 00370M103 | $114.69 M | 11 % | 1,350,826 | ||
KROS KEROS THERAPEUTICS INC | COM | 492327101 | $85.26 M | 8 % | 5,389,264 | ||
PTGX PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $65.71 M | 6 % | 989,182 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | $50.65 M | 5 % | 3,347,501 | ||
BOXX EA SERIES TRUST | ALPHA ARCH 1-3 | 02072L565 | $38.39 M | 4 % | 337,125 | ||
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $36.43 M | 3 % | 54,684 | ||
IMVT IMMUNOVANT INC | COM | 45258J102 | $36.14 M | 3 % | 2,241,753 | ||
ETNB 89BIO INC | COM | 282559103 | $31.06 M | 3 % | 2,113,153 | ||
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $30.31 M | 3 % | 45,500 | put | |
ZLAB ZAI LAB LTD | ADR | 98887Q104 | $29.44 M | 3 % | 868,780 |
Rows Per Page
10
- 10
- 50
- 100